Inflection pivotal as vaccine pump fades

Eleanor Creagh

Australian Market Strategist

Summary:  With the vaccine pump fizzling, we still remain on alert for a development of more two way price action, particularly within the high flying technology sector.


As we spoke about earlier in the week, the vaccine pump was very much needed given risk sentiment was looking very fatigued. The release of another vaccine breakthrough from Oxford scientists this morning has been met with less vigour than the Moderna hype and the boost to risk appetite is fading fast. This perhaps serves a warning of a resumption of the fading momentum we spoke about earlier this week

As we said yesterday, we look to fade vaccine optimism, and tactically reduce positioning in the technology sector, taking some money off the table in the highflyers. Adding some more cyclical/value exposure, relative to growth/tech/momentum. Given extended growth vs. value positioning and sentiment, there is plenty of opportunity for more two-way price action here – particularly with earnings incoming, of which Netflix will be key tonight. Extended valuations leave little margin for error should the companies disappoint lofty expectations.

The richly valued names that have flown higher, being best positioned for the digitisation/Saas/cloud/e-commerce/online trends that have been accelerated by COVID-19. Alongside lower debt levels, higher free cash flow yields, and earnings duration profiles with high forecast future cash flows in the current interest rate paradigm that allow richer valuations are beginning to stage decent reversals from sharp upwards trends. Nasdaq 100 volatility is also beginning to diverge, alongside Mondays price action and a sequence of higher highs over the prior week on declining volumes, we stand by the tactical positioning we outlined earlier this week. Although we believe the companies leveraged toward these secular growth thematics will outperform in the longrun, valuations and excessively one sided positoning at present make us tactically cautious.

With the reversal in technology stocks and by default momentum/growth comes the potential for a more broad based risk-off move, as momentum works just as easily in the opposite direction.

Complacency reigns for now, but risk builds slowly, and when sentiment shifts, liquidity quickly disappears. Then the previous stability in the seemingly never-ending melt up is destabilizing in itself, with everyone rushing for the exits at once. Particularly following the increased retail and hot money participation chasing momentum in the high-flying stocks, which increases the risk of compulsive selling when sentiment shifts. Long growth/short value positioning is at historical extremes and a reversal in this positioning could be painful, with a correction well overdue.

The key for whether the tactical move is one of profit taking in tech and a rotation toward vlaue/cyclicals OR whether profit taking across some of the high flying momentum names spurs a more broad based risk off move, may well lie with the fate of the USD. As our head of FX strategy John Hardy notes, the USD is at pivotal levels for confirming a real trend in USD weakness, heading into the all important EU Council summit on Friday and Saturday. The risk of a move higher in the USD likely having the capacity to spur sectoral rotation toward more broad risk off. Again, one sided position in EURUSD reveals the risk of disappointment should the recovery package deal prove less of a slam dunk, as has been hinted via the continued resisitance from Austria and the Netherlands.

Disclaimer

Saxo Capital Markets (Australia) Pty Ltd prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Combined Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Pty Ltd ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide and Product Disclosure Statement to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as CFDs and Margin FX products may result in your losses surpassing your initial deposits. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.
Please click here to view our full disclaimer.